Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet

At Balance Aesthetic & Wellness, injections are performed in-office following a brief evaluation and consultation
Gut microbiota in 2015: Prevotella in the gut: choose carefully
Our trained professionals ensure a safe administration process
Epitalon is studied as a short regulatory peptide with research interest in telomere-related biology, pineal peptide signaling, circadian pathway regulation, and cellular aging models
This can lead to a deficiency in vitamin B12, which is necessary for the production of healthy red blood cells and is the main cause of pernicious anemia